Know Cancer

or
forgot password

Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism


N/A
N/A
N/A
Not Enrolling
Both
HIV-Infected Children

Thank you

Trial Information

Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism


We plan to analyze the data to meet the primary objective of the study:

To characterize the change in bone mineral density (BMD), as measured by lumbar spine DEXA,
during and following treatment with tenofovir DF-containing antiretroviral therapy in
HIV-infected children.

In addition, we plan to analyze the data to meet 2 secondary objectives of the study:

1. To study and monitor markers of bone metabolism - calcium, phosphorus, parathyroid
hormone (PTH), vitamin D levels, bone resorption markers (urinary collagen cross-linked
N-telopeptide and free deoxypyridinoline), bone formation markers (bone specific
alkaline phosphatase and osteocalcin) - in HIV-infected children treated with tenofovir
DF-containing antiretroviral therapy.

2. To study immunologic, virologic and clinical effects of tenofovir DF administered to
HIV-infected children in combination with other antiretroviral therapies.

Inclusion Criteria


- Data Analysis Only

Type of Study:

Observational

Study Design:

N/A

Authority:

United States: Federal Government

Study ID:

999906255

NCT ID:

NCT01361165

Start Date:

September 2006

Completion Date:

October 2008

Related Keywords:

  • HIV-Infected Children
  • Pediatric
  • Data Analysis

Name

Location

National Cancer Institute (NCI)Bethesda, Maryland  20892